Pulse Biosciences is a medical device company that engages in the research and development, and commercialization of CellFX system.
Pulse Biosciences has raised $13.3M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in May 2026.
Pulse Biosciences's investors include Robert Duggan, Paul LaViolette, Virginia Catalyst.
Pulse Biosciences is headquartered in Hayward, United States.
Pulse Biosciences is a medical device company that engages in the research and development, and commercialization of CellFX system.
Pulse Biosciences is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Pulse Biosciences — Funding & Investors." VCBacked, May 12, 2026, https://www.vcbacked.co/company/pulse-biosciences. Accessed August 13, 2026.
VCBacked. (2026). Pulse Biosciences — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/pulse-biosciences
{{cite web |title=Pulse Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/pulse-biosciences |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated